1 | Methylphenidate modified release | [1] Methylphenidate Methylphenidate | [2] D01296
D01296
,
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
2 | Methylphenidate modified release 20 mg | [1] Methylphenidate Methylphenidate | [2] D01296
D01296
,
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
3 | Methylphenidate modified release 30 mg | [1] Methylphenidate Methylphenidate | [2] D01296
D01296
,
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
4 | Methylphenidate modified release 40 mg | [1] Methylphenidate Methylphenidate | [2] D01296
D01296
,
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |